Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

GENEREX BIOTECHNOLOGY CORP (GNBT)

Balance Sheet

Standardized | As Reported Annual | Quarterly
  Older >>
In millions, except per share itemsApr-30-21Jan-31-21Oct-31-20Jul-31-20Apr-30-20Jan-31-20Oct-31-19Jul-31-19
   10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K
ASSETS          
Current Assets          
Cash and cash equivalents  1.70.60.80.00.40.30.50.3
Accounts receivable, net  0.10.20.20.20.10.20.20.0
Inventory, net  0.20.60.70.70.90.90.70.4
Other current assets  0.50.40.30.30.60.50.50.3
    Total Current Assets  2.51.82.01.32.11.91.91.0
Property and equipment  0.10.10.20.20.20.50.50.5
Goodwill  34.534.534.534.538.938.938.938.3
Intangible assets  8.78.99.19.410.510.610.89.8
Operating lease right-of-use assets - net  0.20.20.00.00.10.20.1 
Other assets, net  0.00.00.00.00.00.00.00.0
    TOTAL ASSETS  45.945.545.945.451.952.152.249.6
   
LIABILITIES AND STOCKHOLDERS' EQUITY          
Current Liabilities          
Accounts payable and accrued expenses  41.039.333.523.921.524.122.414.7
Notes payable - current, net of discount  8.610.110.010.711.611.810.28.4
Payable to foundation for services  1.31.31.3     
Interest payable to foundation  4.74.44.1     
Loans from related parties  0.00.00.0     
Operating lease liabilities - current  0.10.10.00.00.1   
Contract liabilities  7.03.0      
Deferred tax liability  1.51.51.51.5   1.5
    Total Current Liabilities  64.159.752.441.439.737.634.328.9
Notes payable - noncurrent  0.60.50.50.50.5   
Operating lease liabilities - noncurrent  0.10.1      
Derivative liability  16.831.716.51.310.310.48.87.8
Common stock payable  8.58.68.510.10.20.10.21.1
    Total Liabilities  90.0100.677.953.350.848.143.337.9
   
Redeemable non-controlling interest (Note 10)          
Commitments and contingencies (Note 3)          
Stockholders' equity (deficiency)          
Series A Cumulative Redeemable Perpetual Preferred Stock, $0.001 par value per share; 1,000,000 authorized and no shares issued and outstanding as of both April 30, 2021 and July 31, 2020          
Common stock  0.10.10.10.10.10.10.00.1
Additional paid-in capital  422.3420.0418.4429.7427.6420.2417.1408.6
Accumulated deficit  -479.5-488.7-464.6-452.1-440.4-434.8-427.9-418.7
Accumulated other comprehensive income  0.80.80.80.80.80.80.80.8
Non-controlling interest  8.28.99.29.59.714.414.817.0
    Total stockholders' equity (deficiency)  -48.2-59.2-36.1-12.0-3.0-0.14.97.7
    TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIENCY)  45.945.545.945.451.952.152.249.6

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy